Сахарный диабет 2 типа учебная литература

Å.ÛÆÁáàÐ~;¢GÉwzQÜn’*M”²÷8µið)5¶îí½^ŽT;¢÷-Åuœ^V¼õÌ“ür-ÖÖZ
BÐÇá¡8òg{ùCôâÿ|F$ž`¯s”x§Xúÿ¨8I2‚ãlÜmG;âÜÞÂ`¾‡@?°™x2SàrxMDpé^ؙ(Û ç[ NéPa?‰N¼SA1ꀔ)»(©€zQï‚FÖ2Yyæ
î¢0ßê†e”èDyõÁÔJ¦!Š˜ìWû܏ íó¾2³‹è†ô¶ÂÊ2&IF«„„™hæ‘yô¬â6AóÙýžõLƒgºÝnÒ5ÎÞ՝vrØïHùø%%E2B.f¿k×ö?Ñë=9wDUÙðˆu˜QÏ%Md^3ý,#ºîPv´¼sñx_SELd ’­ðʙ‚â5¦iöÔl4nÒG¬ó~½Š=)) °”g»Î5w=”HG„o“†l“ŒÀøôý|EºušÈý!7‡éòAHø…V²¥Ä¥¡{`:¡‚Ó0K ,Ë)Åü”Šì‚ÈßÔñ«TïÉæÌb­p¢¬pd,OBflRvn·Ò‰b9²÷¤$ð#”7Ïǀ5z…#g”4|õ0¹Õ©¡œüp€oÏçp`»¸sљáh:‚¦CeVö%Øܘ®íExƵhdò,ìÀK-Бl„áÐLèp«¥ëM“ü(4aóº-¾‡r˜«ý‚̲ʴrêIœánƕÐñ¶u
×µnÚ춌4iX=Ðp”çômZR§.juç²×›2
’ÕŸn(®ÉcŽåw6çh·$¶°ÂºÀS°ºZ¨ù âDðÉ ŸtÂÝnÿ6Æ’¾M9y™¹p¢ôê=t¿Fj´èþfËÀpwj tY]ԑZx,³Žqåøh RóZ䛔Åeø‰1çØqMXýcØò’Ï.~*tßágI¡ `Pە{®¶‘i¬mJ/¥Jóc÷e1DTÁáølª¦¸¸¶ÉéÂÐÄiÓÑ,4ç‡YðIÝÉ´¯n1B¯˜^— Ö¢eˆçz.4ûE¬hp¶™)¾N©^”±YÀ;f—‹Õ¤F”òÎDАtfž¼@‹”,a²„°N
ÉÇ:J)‰ÛòÛbQGëî0GjÉÊÓM¢~ꌨ¬ÞŸÏ¿Œ9®ÇáóÍú‡ó¾‡ÐG¢×ì¦7âm†–1{($Øü擷‰¤¬ÄÌLæMhX¬oéèéEï´ñ^³”DôMăi/•ÔwÒ¢çè:¤‹/¥Kn>¤Î–ìŽLc2ÂÒÜIåã$aŭ܊½ìçWiA„D°^Á’˦1׉§•õ%ô÷ðâÔÅådgù–‰ç #:šX†»öÊyDpèîõY‰

™‰ÄÚqÁ4“SŸÛrAdΞ.  yÜo¸>“ØrvhpmÈ­ÿlS78ð²ãÔ·MªYúêBý›1BÑ}ø^i™³Êz>eᴣ蚒ãðcD]˜Ä·l¬èÇ£žC){O’ϐüXæÚñB¿ôÐ,¯±’©å«šüÆŒM ¶ÆlµwÐ7B“µ½BV),»¶Šø,ð3¥i/Հ²¹RÑl¸€6SÐÙ
D¯Ä΢”ùYàî°VJ¬Jõ*0‚É÷·6mÍËÙ?³©¸üªä™vVEz~aÉ5[íüô‚JRâYfêïáIûú„9E¸8LÒ6ôÜàDmƒAA..ºVYûí‰l‡&äµk6u9uÁ‘Æ?‰žŸcãÅ]‚ìò
ð¼ºÚ´:êÒ
ש‘ÎΌ‡Ó®ýö~ÞÉû¨
DfUÙÁjJôóiPFŸÌ°ùsk¬|/f¸8F+îwJ©³5aº‹O] ¿[~y‚rV÷üqé‰KIø‰K‘š³I‚·-„Ù‰²–+,v¥Qف±ÿ¢«”€ep¹ý¿n ÄʍpÖêmÖÁ™ºú8Ä)LÍѺñFt{=Ä­cÖ++˜ËȐ3†Å1Ì@Ûë|HidîØÀ’=%»2¸˜¬Èª/©¼ÐüL[ôŽ
öóI£V@‚Ò*÷†xkN”9Ž–i²ëD^𑒯o£ó”b‘(lbì®±¾èݦË[´}cƒÝÉÍͱ¥Šqœ1|^FçÞÎ:í’
˜Ãu¢ú÷é†Kt•CÝ`§ØÔ~µò%7U¾äÍÉś=¨ŽËÏÑáÆ
”X…6″•(9JE”W7YÈã¸îä ^œíˆKq‡†_÷
Óø¿ÒSÚÉ>UŽkÖ¼æ³ø ¡ø‹U»œí™ÍÖæsÍUߧ
íè-·l¦ ¿ÙÑÖÂtv×?ú…„­èc®ÃÜNÇmW^ŒÛx’iµªœ÷%i¿ü¦åôJK£h’ÊÚ8¿ocysÿ$̹ LçuôÛ®üö¿Š{5oË{ˆ÷ہ«2ÁYw‡žÜˆŸþ0I±”ä4ŗR@ÁÈNX
|Ëû(€AAz{AŸ½+NÊ)J*¦ŽŸÙïÐÈÔ¸eÚْHÍpô½Þ‰i{þ7gZÿvWœÙÆ~/ÅzOþ½½=(߁oôÛmhJEÇ&§îeÂó_á–h’`o~ShXh]:ʀ»ªWÑìÚØÍîdôÚ
¿«š]ÐM”]“±”Ù%)V; »Ÿ1B88h&žŸl÷’lâ¬MÏ óM붨ʢݞö¯8ïð†*5(g+vœ}åܦ»”xs¾¡¸‚ioª:s—5óӞEt›‰Aª
åß*šéh©¼V(@S^~÷}Í+˜Åhkò-d]››‘s& )t ¢0‘²¥X¶RòK‘`Œ$hª3ŽàȺpúJÛWsÀ>G±ákb¹Ý4®ÙÏA[ଃÜÞÌ¡V¿{ofúÙ OÀ.#çܐô¢á}OúO ¼Ýf{ÞàU.ÈÃ;¡CŠ}; Òþ¡¿£¢IÄÎĝu»i§ê³w©“²òÏ1(#µrXï‹ñL”t‹y¬=çoa_wqA÷6^ؑ‰* âŸ1úï’âWú½Ð÷ño¹GIïÚ娌þƒ®†(}ú.JƒWÿ’úúכ#;¡ŽKƝš-]V]¬ækÑë.JÑÂõûëñÇ)X ß@ˆ,m:Á´oœ_«C‰ž[ïõ6bЌ.”ïûC…x^Õ±lË.”¢ÒÔ¼škØm¡×m3 ]NíòHÉtgBóqÑkàãÂzÎvy2(•aO^@Ü Ÿ}ªÖRÁJ4?-Bþ´ó›&Xæ¶ÚËbúHU½˜V}°¿yTZt¦¨:!BþTié£
ñp÷~šÞ/«Iok©a*;“©ÁIbå EÿÏFPە­*d*¾‰ª~Êg=#ÄQž®±Þûõ”´g†Ïôڊ>ÑðX6~ ¹°YÝ½Îc5ÕtCcõ¹ïH —€¢’Yš[zÐ ‚Xt£åYîÓCÚu©×rOù£N1ðJŽÉÎ8Wkf‡›}„+å²ýP¯ãײŠlÊЦ…ú‰
°µ=¹ñß6½®Rö¡§â
Bq9_5H#¤í)G›™¯ªrŽ×ýkŽnú
ôt®´¹›ìví@4=c‡8­¢$¹Œj=¶r¾þþ]þáIÉAŒ­úÁ’òä
ª¢þ@H9×Ô¤ºz“ËWù˜{$§qõ?šž(aÇÉ0Ž³Å(N”0RN¸ç“ÈÍýï 9í$øSÂEè£ Ð‘±ceXtHûË;øÿ¥äsöà`¤¶3@#ÇZ!ÓA!ŒÊËÇၠk’Fqx¦k•‘£NäŸRôÎr-ùjñeøðÌ,
§ò±‚¿LÁ¾ûÏLÁàs.!¯oY½6ÍÒgàpž)ۀb‡Ge]ãqýXáß¾‘Úãè‘ê[ÉiʊHŽM‰[±2=0ϱ5šk öÛûº®Ù6N;$rC,gÃI5Ä ®R®Ï/>ÞFÉÐbAH¨•Â¶ŽÂJ9cY,#ڊmó™ˆÀ]a’„ؐ’³í¿/ۗº¤påkV^}ú‘Š>픜äô¬CWìµKrRK‘Ç܏ìÙèoåA{,Å]”ll•-šUmžm`ñÐè±èg ÁGœ”^{ð0Uy7~ÎR3¿
¾.)…ÎLøÐ$&¦ötäUêŒ*…—•Z¥0ŠR¾’WúU’ êÏXëe´’Fx‘݇çVM-£ª.î]¬·zŸSHXRr8#ÌL”töÀ†ž&©ÂÁ”cFÕÔ©†€0HÆQݟÇM,Ø/—Ѧп/ÂP2åÜچÿðGwü;¡›
T¹¬`ڀU¿è÷eÿ!š¢ß¢Àrp¼8k_Ä!_Ê+0ØÍø†ÍãÇ7¾ºTXè彏YLDûïu¢œü33B‹D Xû§È¢ço™+Äa¡ŒT[3§¸(q…b5盀ÑdšËù@^JÍ¡¢öª>íÔìäÌìœ¯íµ³²
‹È£þåvÖîÎ;‚h—ÅøÎ —ÊzØî½[aKrª“/MèïÕ¼
݋½‹#MÇNñÙåçirÛ72ÒߏËvli:ZRTH•m-þ1ïJæw¯k€š(PjRäõ]Â_¸òf’{y~çlÿ®·Ílx8ΊЗ›àÌgMp¹èýÚ™fz†FÁ3¼”à
P l’Á¥‹ùýÁŸÚ-ý׶FSLy¯smQf¬^™. ”£ù†h5¯sdÜ*;íQÊ$Á44UŸ¿G=—‹ñtüNq±4~WÓ°-m•-i³o›ÛšËAª|x|_ky:ûBµ”n®•,¢„!oßc»?ȽÇvrá{e‘ú3×vÈC«[àM}ïþ@Í’ý4 ºYŒ1Չ9Ô­Óå
ŒäXCïsæθ>™ýè°+Æʘy;ë•ß&BC7qÍÇLöºXt3·TZØH½éMA˜Å4ôA˜oržóæû4bH%ù êQÇý_´ ûmšzÉe©l=.«L›  ‚ì~.Ù¼T:¦§†)È*`pª; šð.–¯
Ü°É~çØ©
x@hœoéVêÝÒQ]Sq„Î:TR[~¶³!Ú݊¡ïª¡¡/z¹æ±W5ë}€fŠù;çúaÁÓ1ü(xöökdK „!#ÓÃfuv̺λÑmTvfbR:ƒæq–Z§°æ 1dyāôÌÄlªínVo’S’=|öÿéб!Xø›‰xß¾û(SÇÒZ&*? ñY’ô¨ñÝX-Ëê¤ni¥ Ú[“«˜ÆmIº~䂀ÝQ¡ôG_Ó}û’öQÂ9CóîÂ!mD‰,їh³Å^ÜÌë ‹ô¸œW0þ š·×6–Ûs©’6d ‰°´Á°+›SÉ.hb3″f¡1zðIj–,]¡ár€–¾õvíûòýÛ¸“‘+|oÜYp©y²vI±Ûý`ÑÏÏQ2­¼©Cx¦8UyÒ±éuž}TCGö¡FÍþË7’ôDä»hwjIÌ©jæçaÒàž¨b~•â3F¿Jk0F”øŒ‡!f|•’q™b×ñ»Üÿ ¤!:Ÿrtæ¾WQÿ½ØÄ°iñÊÈù¸6=⃆¤ ڀ,‚Q51RÛZ¦n§yªåé ދZE÷.H„2ž*i³”îÁFœZRt°‚ªïŸ¸+È/,Š‰ö 3§|’S!Œ”8S¢Ï´ÿ–òýÚ?L>Feúށâ}þPÀŸ˜VRI+:œJ5ޏŸ8azòž€Àä”`*YFü§ÜñW3ÂCLLQ꘹ê&ñ;ù§â¢ÿ#^P«j÷wP«*u÷÷‰/…¿|—þ¾L4ú{R+ûoÖg­ÂÌ sÒä í©òó’»–H:5}ÿAù];V¿+õ=̺Àæ©mXmK±õ5ºi{Ɩïþ 
.c;¨ÕÀöøû²—Âåß}Vá®´ÀU¬dc^ÿ[ª÷ŽÊwEé_×½ž6a»üŠ¼ÈuÖÒ¿%,´~s7È/þî ºvcUîbù©õkâT¥BËkÿæ*
x!SØs9°Jêã¦O¯åø¬ùÒqówïíŒÇïã™ùG90cþîfóøÍXó›Ãco̵v`’2¡¦2§±”è7° j+¬f?ò]€u嬹˷JŸýmȆ£.û­ÿÛ_´³ªª³PÚ.jÞÅç·z·ÏŸ×Õ¾Xž¯zöÒßmgošú‡cõo‰Õl¿ó¦²Ë-p®d`üÏÃ9•‡«›‡{;×}îí½“xxîO쟶ˆ‡÷ǑOE gjûÚ
endstream
endobj
203 0 obj
>stream
hÞT•KÚ@„ïüŠ9n”ƒÝ=ƒ„6+qÈCÙMîÆR0–Ãþû¸º&å *Æ=ÝßT›j»{Ü
§›«¾M—î9ßÜá4ôS¾^îS—Ý>Oƒuý©»•_öݝÛÑUóæç×ë-ŸwÃáâÖëEõ}~x½M¯îáIß×ïõuêótŽîáE~üœžïãø;ŸópsµÛlŸ‹jû¹¿´çì*lû·öò:f§ö[JáKŸ¯cÛ婎٭kݸõ2oúÿŸ-Vž[ö‡îW;-Zñ›Y{Óþt0:R[LbL€n¨kè%cL¯¨ºeŒé=u„{j«•¹”ÿMΰ…&gh Éé—Ð…ÓâÉl½p‚_È韠‘Δä¶NNÅY¤ð$è÷‚a~8ëÚb”œ‚³hñu•œ‚œJN±½…>(9JN§’MQWÉ& ¼ÒŽ–“Š­g®ÃC%³@ûš½ðÆ[ï¼RÛº§F_˜Áæ#×ÁæÙ;ÏžuÎîé•XÎãÁ˜ßîC(½[A3¿Ú:=ô4OLO?,™uÊ9-ýQxèÀÛ@섞ç
ôÇîX §¢G‘=µþFö4€?’_‘3ҟb`½‹àWÓ¼{Ôäà…ßté¯ñ~ø¿±‘?¢/‘üv?ùí>’²Ex›Ø;{ْœ!¡nb­„ü©ÔÂYk%œ1•ž‚­)÷½h¬GuÎ%êj;3Ÿ2e¤þ;t8„Ö52 ¯£·Wå¥ÌðxpzZ„‡I~Ϝ0`{à5¶Ö’èÄþ$ô9+ñÒ$39s$Ð6ˆnhU{–}™œ8öœÐ˜¥ðoc¹»OÓ3FòiÈoãeÄÆgñG€ ‹Âr+
endstream
endobj
204 0 obj
>stream
hÞ|UÛNG•˜Ù«0,LÙ&¦;ñöNßæòš‹-9òCľŸHlÅ ‘üÉ7çtOϲ)€PO÷tÕ©ªsÎ,ß^*út—»Ê—o$IZ}Ì{ªñۓ¶P´XÝԚV·yíÏ$ý†ÕêÆýû’3ÉWŸóáí¥SC0Y;Üq‹¦A$eÈ*#¬¶.âò»»ŽnîðöÝÍùBÔu­h¬Tmü+¶ÅÛNt,Š’a6MҘ/d/$Ë®k©øBIœe„
»Í±aÙô Ç._ô¸“¹³È¦ÉN¸
—} $+f»îÉ^Z-6§EYüÃê]®E«jI)dß5´ú~€Ú¨ºî¨.â~|PF4O££”Ž«¨LN ÅÜ£Í–%euìó-Œ0MÛ»„ÈkÖ õ˜Ðùþ~Ê¥Fè‰NâÓê„Êäِ}Êýªâx|.¦÷ùÔPµ¿vVL«gUéÖ@#¤é»G³±¦ LÊj£‹EW:Þ Í2ªÎÐ?z.^ˆ—UŠÊ7Û͵0쟱ֶ—ÿSk«†çUY…dEº^nD®­ÒÍ.M6ö£ÈQB³¯Ò¤¨czØ7Ç+Ë¢z5`/¦EŠ>V¨=òþG¬Þaõ™Dß+úZÓ{ºú€­ŸsI¿Rþ’ÞÞµJè®#Ó@>=ÝÜúíÛםèÛëßóËü’§–ÿˆ¤×4«…´®õ·^2Lü49*PÍ£Yuʺf3´e¯Ø(½IæUE³b¯ð$³Ž—Ö“ï(9

špåÄ4ãø·Ëu‹·2·.Â9æä:°|£ƒœÍ€ÓTDƒÂt‹›÷8for’Þ0´- Š’Ðìä5ebKr£Í
+qâ³HÜî4-ÀÕ÷#
=´­]KGáÀ
¡j ˜Û;Ñl—öªíýì`à”Ê/X‹hc0ÛÁ´–îp£D˶[;ðŒÎè ÃQ㎳-GÜt.uèpîcԖAéþ±
-0ðî
Èug)ô®ë•÷?GtZ¦‚‰p¯‘=؆Ó@µ¢#¼fgn£v¼ç€‹¸ìð0]SÀ0¸ØûrÏkG£¥z(gG®vȓSW7dAPGçÁpÄÌëø5U%xV†‡(åä´*“,JÃnÏ+n¸á€û…­XajíǺ]L|ñ­ókDÇ6¬UciŒŸºk ÀDCy­ÐR›Gå…ÆÖ]˜ö5ÿúüÚZ,94Æ.¨~¹¤§Ï_œ_ÀªÄc£²Î‘jÀ_׋N”G[é[=Ò^©Î£ø4ÄÀ/Ä 4ëù(ë{r[wëŠ)ɵ³#͕ëb3ú¾Ž½û:Öþ먝%@Z‰ž0K€¨é¯_òù¿ ÃùTõ
endstream
endobj
205 0 obj
>stream
hÞ´XyW¶î«
ÛHÛ]څŽû®(HWT‚

b+Ê*K#K³4‹ì ûÒ4
È”‚Ê”b£¢ *î&F1fœ$šhÇSävÞ¼Û
Ä™É›÷Ç{?…_YËwÏýÎwÎù®o˜ áŠÕvë>Z1ÓÆÇ=8Ô3ØföJ©¿‡æÁtΙàÆ㶙¨)´ܰ習ãyv#gŒü…õ˸÷~Y0ºoÜÄcÞÄ3â ybÞTÞooϋ’åEðâyxù¼2^
¯‰wšww•w—÷ïo¼W¼·¼ÄhBDü…˜E,”–¶„áBì&üˆP”†H!²‰â0Ñ@´*¢—¸I|J?Ho˜ÞH==¥^Odg`€o`Xˆ»—¯¯å|‹E4óç͛o¥»X¬»°ºX0Ow1_w¡ûjÁBÝŔ݅¥îB¸@¸@h¡´ÐZè -,t:d²…ÙB‡l¡C¶Ð!/Ô!/Ô}µP÷òBÝ˖ºG–:@KÝ;–¿½£´ÒZé”´ÒEh¥‹ÐJh¥´ÒZé ­t€‹u€‹u{_¬C^¬C^¬C^¬C^¬C^¬C^¬C^¬C¶Ö![됭u€Ö:@k µÐÚÊFìëíj>mÏtóùÖÖóf/˜7ož¹ƒ{°û–È Oóu{æÌ1_áïoî¨y-ÄÜÑ3Ä3Xæé1Ç|¨Ì}CÌÝ̓=½}Cð¿ÜƒýÌ¥^ ß
tõ•ºû›k0½Ü÷xšÛHƒƒ¤ÁÚÛsÞ-)#7œàä©ÍyӈYúó‡Ÿá]0ùŒ÷9ñÔ
ã}¤©©aÉkáõñžóþ‹XH$ëÐ[¦W¬÷‹>«_5L؇ÃdÅRNTmf gm00¼Âp–aá/#ÜG327Ê6‚‘Ö#søùÑüû£öŽzü^þhÑèãÆ>ÆW3nj£ê Mš˜¨ÇîÛj:Ì4Îô³)frÑdQ„èóslœxÓxÃñ{Lj#Ѿæï|4R6ðc8ñ5ês&»…h[ì44¡œWh>¸ÄˆÏÑhÔ!’0€4¤ŸFÿþ!Hñ—ms…0:ì¥9!4*R¼§’×0ŠDpxÌAÛJð‡*4G=áƗaÑ҂§
ÈF´ò“?‹nø´nv—í–åÊK£ÄW)Áí̤ŒäTÑ?·¢ð—Å°åÑyúÍÐ.œy¯hŒ–Äu°Ð‡I0S¸ÓÇG²³É§½£¹ét»×‰],?ÂF6Npw,„Ë)µå¯9ä}ŠŸÑåÒ3@…C”ŒAßÀ2!’­$·Ò0ípa©Ž£c#ɉŽA NtM¥ã+Hn€æg¼æýD0°ÆéÊ×B(‚Տ¾#X|Š4vÚº…»jƒNW–å”T‹AHT)–3Ÿ¨œ>@†Kg¡,äÄ~ÈE€ãF:҂äÇõBÙ
Hí7î…Ñ`ã>Œp°ûIXpD™]ÎÜírY½Ôiǂ„ÄŒÌhֆÎ>‘—yˆ¼ù¢Ûuù»2yvÉ^ÖxdnxbV³;0Èså3g óþ+ŒøfM/2*`1&¯æR÷cя·ÐXôތKÝ뤧+K³•b~¼|q‹p*ÿÃõ¬…è‰Ú‚|ú‘ !’[D£áH,DÇPÍOè…öÇ0õgâ»Çà¦úßazÑ÷tᙦìˆNó-í6.ŠÞŸ™ÅúIæÄìϊfܤë»ü¬aøw˜Æ!³ÝþÉrg–ÀõŸi~ÜU¸ÿl¹Ct‚)¤“Îw@”DÅ©È
ÿ)¡M/…77ãÍk˜£|ƒFnÝ.÷Ù,®†i_–5Ëofžž³Ÿ2C²aí¢O`qYFQÖa–+ã¾}âSMÄ»nÐ¥ÏIh£Ð}õ×äÛZ
pyÇÑå×!­Ï¸
€1H€š
Ƃ—œ8á-MwD?.ºhüÜeˆZÕ¸ýco±à§y;·.!ò‡%0f}ÿ Ÿì:7ù”ØíˆPðÑ]>Ç®‰zZÛ.]mwYåííå)F£×?Áç®]ëEv®»V/Ù|ù‰JÙx¦MÌ÷“Aݧð¨—hÃ$a.@è,„òg0–‚Ÿ,gÿˆf¡Ù§¡IHðt>Œk’I4…KpE(÷M`æo½üúUçÍ;Ÿv.Ac|Ò÷%y±|”ŽkÖàúùJS?K¸è?ÔOs{»÷‰,újØ¿ÖW)ƒ´;ŽAÒ1⧏¹aõ¦e—’?Dr{hø}œ„aܪ¬ür>ى”Üè+‰‡”HõrµqRò(Šr¥ûS¸àjèÈH‡$rà퀞Ðñö!cd¼}.`ábú¯Æ™EÕÃå÷ΞUÞëéQÚlß.·qdÑtKáj8w‡æ_ÇA%âÆ`x×ó¯ÒüTôGyñ%}°„„@ª-MŠý(ß?¢¢
Q÷r1/|‚2H´”â·g„úK ë!Þ`ÖýÁ¿Å•îKQâ0ëi¹Ü>|¾ö`¢åÕV»ÒÒ¤,DÃnº$¶Ô‚¼(ԃ^ ³—gU2`ؼdƒ_ª—o ëï»#ŝ‘…gâræŸÁk•^„ôncÍZ¶ žæ‚7²^?8”Ê¿9ÜGÃÙä,JÀÝ?tëԏ”`Ñ¥½xòfafAa¦‚©?›ÒÀևäyû‰R¹LÅÅaM¬àÍé É^‘Š‡¿Tìëµ1ݛ‰ŠÊ̌cù¾*ý:8«¢VçD)I®èy9Ž·è¨>àJõÿ1Lþ4]Kû¸³}®*cÎL`ºv;_$+å‰kå³=ÏÌgÊÎEVN(êUó”
’ÛH)cjÑDÙPqÅ$WC+•½9¤ŠV—©AØ~½å~ã7‚ç’ÞTQÑ0VŸ¥øÅ=€ó?˜«9—q¨ØÚRQbå$Š†0¡1…6äeˆv âmbbHdñ°Ò¥IåJ½C5~Í膲K©Ê7þ÷e7xÿŒÃ|_h7s=¥E:Ӓàڋ2Öû[Rðäq€ÿ™ŒÍ~‰tO´9…½ÑS”ˎ͋0kœWéPZg–N[Êׇ;9£I¦AQë4Y
l¢o‚ùquEY’ӊ2©hùzÍý*zCŽIBf+ÝYµ²š½‰œHTÑër‚ÊœaRxwàuK¥Y]_u¤òrãצyåÙ%%•7M›sjj[Dµû;lVøïx?@ì=‹Ü”–Jgˆ¤0قïû5Äò£âúáÐ%0
‡)ýÆMŸBˆ’`ýýÒ;…hðå­Ô&ƂMîÍüiÍ˲Y´@ýUÕ¹þ›¢®ˆóvÇŊ}®‡¦3ï;ÄÉ·±Èò]öJ¡ ‹jŽ¬aÎ>Þ? ѳ£¶²² ¬$ƖÎ*jÎ?Å~ªq£ÍêÍv“wøåı±¥r0¬»dts×UÚD^Á¢kÐݛ¢”“êZœ™MZšT´½†–“4áF‘êEt´|ãЃMšílP“+}%¥TNJitE=Šäfâ}Úm­tùè…kêNF°ŒÜ°XþßV¼=€Y-GŒ`9kEÇøÊ2‚™`Y†Â—å¿ùƒq‚çƒ]áŠFyXªCœ

2OÐ׏J$åìC­N”u²&íýXz~I!ÖICIåáêžÖ¦9Å%ÊË[LOe5Ô¶‹ŽÉÛ׮ݳu…¯xçLr¿,f7³fH)Ï)û1£[“Ð×5Ä?ŽÇ
ÆÿV×ik§DÍ3@V>R¯zM½d{½D»TbA#Lúü¹™e,ˆÔ’©G)(ëLÍ9œš¾nâ§{8ëW›@¸fšDãiREÃõ÷ä=
vs?“YêãT¼ÜNU¯¢msöc¨zºHqK“…C4š«– yÜN²•ºÒ7RŠcIõQ:&rC–š-液’ÕÖþŸÔ9ЎrþsґµƒôwÙÈû¹{ýD+Ìàø0CŸ3°”zùvwöýåa“¬DÈ F EØ>¹=°MÆíÜU|pƒ°µ/ze;{Ü¡x¹­¥”Æ}«çzÅg±_ïþûý¢yOÝßkï)mcø°³Ö­IŽf;M89ÿã~¸“Ф>Iÿûtæ”3C®½08`ˆ5s SE­Ê‰Æ”¬¥ÓO(”0ußevß`ûT%7{Dßû¼D btĕº1¤ÒHÍÂàÁ]ž§O$Ö³M¾9n¾”ßW_±·kÊ^&.:33å_Œëçúµdés?À6¡
ŒFFG“ÉA¡éÑZ¶ÆaÛcØr³¹™m>qþHÓRŸ¬`Qåæä’ðÕ°Ð6׋Aú‹ý]ìÙu›]æ#¾èêY–ˆWÜÿ2ü;æâíüڇ,¿sÕÓC(nÃ,ì?gݳX¡ñ«oÓʷʌԭTÔ`>¯¢×
=#º4¶Ìœ¼
«)~5ŽôáD?¬¢¥tLóéøVæqw3,¼ÉÂnÙÕ”,‰€íôՄ‚D£Sh.œ.(¾¤J6;ñªv$­÷†øí`’2sØ8E$X•¹ªÛ½€z/t˜q‡ÁŸ1|¨0ž!ÞÏVÑ*È(x”úùlØ ªTyWƒÝãJßѤÛ+Œž’’AF¼Š­ÚNÉå«SÈ/¹(!Báô²=͇£ØàÆxÕIы–¿Â1Ì2© `LËÂٞñ®Á{Ù°¨=Þ˘pŠ¾R6`N(´Zº– 뱯ފ*6hLWà#7쨒ðÝv½¶m‹°r®æá°B]é‹É˜´ÛöùedŸŠâƒõO¸‰ê¸“¿Ý«•ëE8~ ÂM•˜ÿWĹkª.ëLÜ
ôa••twZZ ´RqCf^hýÛæړ`4‚Ä”ãÙûíCC33ãŜ¡£Ú)Á¹¡¢ÂÝG©ÐĀÚ5ýF·žòükxΖõCb?qâSx‰›á6öñ)bW##4{W`~~¸xp.Cë¨À’×RÎ3ß½R|ñ9Ûpìúg Á.4
þ‚ÎÛ(óÿ>j««cTwâºØã{¯Î¶7@åŸKÌèv•Áך·½_ËÃx˜ÌQ0Cpú?µºñtÖäÖ]Ωs×£Ý?1°w§‰àôŽ¯í{ÙӒåˆd¹r»Çnvͺ…Éë
ÐxRšæqzpÚ5s¢í–ËÑ+ÛØöåYÓE;SæJV‹×ìtˆ`—eåÊú÷ìxUt«ø^cø^[Oi×$Å90ë6>”¤b¼ð(Þš€Mµ5’VABݙzÉ£YÜì¹>+ñX“꿉ÝäŸê-ÚWX)þæu°‘UÊ|•mïË&дwâÔP—HA§K¤­ï”Ѳ¶M__¹ÔÐÔ-DµtFì
Ž—2¾{}ŸnÜþ`)!Ă7œ| V˜ä™ì›úa¼©}¢Mô¦õ«—£ ˆ-/²¸i’–Ö_ÜûŒ&×g};ZÙZÿmuK˜VíY»“M§
ÀâEý—%ŠMïÝlP‚žJG7„/+Ì繦` ’ŇD^”°—î*ZJªÙzåÑ£ß«U]0»Ûø[…› âH𦊓%tæô„ãœBJ •¾ÂR0þ«mµ]®Æ®q½ÅgZ/‹šãê÷VŠ£½Ë¬™9›„+*31ªv™óêõ >²ÌÌýìæa™¹õظ ޘ&e”³²#ðqÑ,£ƒ3¹Dà(ôkM ®Cӓ°w×]£˜Lނåê…Ꝑø^h´¦âF’tÜÎßk#¿Ž_‹D†[Ќ¦™¹ ɪLJ±P¥ò
d‚ݹd#WH ­PÈ!;hõ4µPð¼ÿu’,(ÚàõŠ¿1áØ]€ñ͌AcÀ—×Xœ°8xO¸cŖD™¾~ÂÂgԛPè/v“ØZ‹fŸt¬Ã¹©gïWÌß>iªjÓ¤à(>»¨R©NºY‹qS±Ëè€uçÁ¢›1øð©¦ÔtPÛrb°”-ëéºòð}ìy4ô‡Ú)O^¼èØÚðS›‹±ùÊͪÈWœ¨¹eš]x0/¯ðš»iKŽ²¾AÔ·­ Ð-Àß.X,]µ?(nzºYrR’œ‘ÀdJð¡8‡·HèsZN’Khy^n›žW´ÿ¨ô.>_]
hpc·%Øû+ZRØkmyñ“²ãÍjl^‰¹éøܱ9.Ü#VºÑ¦ò8§$,‡côy˜F֔WÔ1õȒŠ‰Ù†s…F’tƒ]Xw×^Á3ßh´ DxPy$»œ9֗`šÁ†{eÄ3ÞÒâ|9_´ÿKr#šFEÞ¼’rœ9
[óÀü᪦
9Z ö”:~Cْõ[÷Çî#³>ºð~q©¨¯9¨d:Z‚6Ùo—ÄDdfÅ`/€u6®K£3Ø5¨µü!ªÑøN‰òimÀü€vÖæ
iå‘B£](„„zˆEüàÂ;ÊæöY®©,kЃi gú¬*â¢Bßà_»; €ºÓqõxp¹oHtBL»ŠŽ–†¦…2áa™e~,
üUO8&)ø¿ŽT¦Ñß%˜«Ñß·š
ú%`YG7V‡…°½ZõmTŸ=ÐQÇöžtËÃê«+*®Ì/«¿ešS”Ÿ›ÿ›ú®8ç»úymû­”¥qr™³&ü®»‰#8£ËSÆ}¤­äU7~À‘¸½ÔÖr?6|©è½P4Óe™™ÃyÒ95É#DäY!Õ ,«A“rÙÔúXh›5l”ü‘
ìÿµå͇É]ܸâÛ~øõkµØÞíp®º/Æ’‚¹jò,392ýL
½’ó/T‡bŽIt‘pƒ¬¢ù­:>µs|Wc` ŽÈò?§
7lG˜ð§9;€§È¤nâÄà чóª±hÔJì„V½ß׃©çAòÓÎ+Þ
ìqÍÕ+™D’á‡Ð”ÍkehìŒÙa`r÷ž¢­¤†=RÝ|žá7j°K—v¬Bn媉÷áõj}¼º«&îÜßãtF®¾üÏ1æ ÀXÞ
ê/Ӎ¿Æ˜>x°¼…PÙaGás,¤S5¤W0_Þl8ÓÎ66¿ülш^Û­;dîłÇ}Mq#÷ÜR_¦c¢°áßÌõ/µÕe2u²ˆ2VyØÓF„íV,ð—ÌŽóÍr£Îié™cõ9/0F‡mö³gvx•6IÙèò ¶ÏDgÃÄ·ùùÒÄhyUyZ)ÓÖp´­4µÑû([½×­p’3ËÁ=HÊân¾ÎZô~½]‹‡8 á¢ïS¦æÁÁsOY¾õàÌ*¾…Ùz·Æ,C¨è g׺T^

9Çx¬)QV53’ÑD]*ý§”G´F˜s Œ™ÓÕøìfVSEYzZ˗+9ùX¤l+TÓõȨžB…´¸Ò&’GüÃhx¡‘a†ÑˆnC5¢;+;ÛÈFääŽá>þ· ؤnŸ
endstream
endobj
206 0 obj
>stream
hÞT”Oo›@Åï|Š=&êvvâ$BjœFò¡T’½cX¤Æûòæ­õ`ë1̼ýíîùv÷ºúÅå?æ±ÙÇÅuýÐÎñç~8º»wÿñk
ì/Óô’žâ°¸ÂU•kc—åÛ¯õô­>E—£ì_ìý:E’öìÓÂcÏSÝĹŽÑ•…T®Ô¦rqhÿ—m„%‡®ù]ÏSõR­:P¿B+õôƒéP@oL«éGƟ Ÿ¨­ö™µÐ5õgèktÃ|…nM‹‡ŽÌ7ÿŽqø¬Óˆ{O
6ŸøŸ¡?›’¿‡¿’¿`¿žüþ
šüþ4ùƒå_M“?XùÕȌ“üº&xµaü’øá#äWÔ
ùö”ä`–tþà”tÎðrªå$N«Mœ[è†ëš&§šOdÜÈ©È éœáÒ}á¨
}੬UìW=ã8Mwå>ªÌ³r‚µ4õzIyGj>Ø»x6M=fk¥³8™Åjɼ¶E¶Bêø[ÿsJÁb’:]@̲Àñ[)“1N˜ñÛd6—y^‡Ö>6›˜Ê~ˆ·oÅ4NBü²¿ Œ
endstream
endobj
207 0 obj
>stream
hÞ üü

! !”!!”#”!#$#”$%$#%&%$&’&%'(‘&()(‘)*)(*+*)+,+*,-,+-.-,./.-/0/.010/121023213432454356546765787689879:97:;:8;=;>?>@>=@A?>AB@?BCA@CDBADECBEFDCFGEDGHFEHIGFIJHGJKIHKLJILMKJMNLKNOMLOPNMPQOMQRPNRSQOSTRPTUSQUVTRVWUSWXVTXYWUYZXVZ[YW[ZX][Y]^Z^_][_`^`a_]ab`^bca_cdb`decaefdbfgecghfchigdijgejkhfkliglmjhmnkinoljopmkpqnlqromrspnstqoturpuvsqvwtrwxusxyvtyzwuz{xv{|yw|}zx}~{y~|y€€}z~{‚‚|ƒƒ€}„„~……‚††ƒ€‡‡„ˆˆ…‚‰‰†ƒŠŠ‡„‹‹ˆ…ŒŒ‰†Š‡ŽŽ‹ˆŒ‰Š‘‘Ž‹’’Œ““””‘Ž••‘––’——“˜˜”‘™™•’šš–“››—”œœ˜•™–žžš—ŸŸ›˜  œ™¡¡š¢¢ž›££Ÿœ¤¤ ¥¥¡ž¦¦¢Ÿ§§£ ¨¨¤¡©©¥¢ªª¦£««§¤¬¬¨¥­­©¦®®ª¦¯¯«§°°¬¨±±­©²²®ª³³¯«´´°¬µµ±­¶¶²®··³¯¸¸´°¹¹µ±ºº¶²»»·³¼¼¸´½½¹µ¾¾º¶¿¿º·ÀÀ»¸ÁÁ¼¹Â½ºÃþ»ÄÄ¿¼ÅÅÀ¼ÆÆÁ½ÇǾÈÈÿÉÉÄÀÊÊÅÁËËÆÂÌÌÇÃÍÍÈÄÎÎÉÅÏÏÊÆÐÐËÇÑÑÌÈÒÒÍÉÓÓÎÊÔÔÏËÕÕÐÌÖÖÑÍ××ÒÎØØÓÏÙÙÔÐÚÚÕÑÛÛÖÒÜÜ×ÒÝÝØÓÞÞÙÔßßÚÕààÛÖááÜ×ââÝØããÞÙääßÚååàÛææáÜççâÝèèãÞééãßêêäàëëåáììæâííçãîîèäïïéåððêæññëçòòìèóóíèôôîéõõïêööðë÷÷ñìøøòíùùóîúúôïûûõðüüöñýý÷òþþøóÿ 0ò
endstream
endobj
208 0 obj
>stream
hÞÁ´ °ŸmÛ¶m¶mÛ~Ù¼lÛ¶mÛ¶í¶”0AJ0‚‚„”4aK8ˆD”2QˆJ4¢ƒ˜Ä”6qˆKòS€‚¢0E(J1Šó%(I)JS†²”£¨H%*S…ªT£:5¨I-jS‡ºÔ£>
hH#ӄ¦4£9-hI+Zӆ¶´£=èH’:Ӆ®t£;=èI/zӇ¾ô£?È 3„¡c8#É(F3†±ŒcøŸ‰Lb2S˜Ê4¦3ƒ™Ìb6s˜Ëös€ƒâ0G8Ê1Žs‚“œâ4g8Ë9Îs‹â2W¸Ê5®sƒ›Üâ6w¸Ë=îó€‡ åeü
endstream
endobj
1 0 obj
>
endobj
2 0 obj
>stream
hÞ¬XMoÜ6″­¨] ‰×Vj¯íµÇëP—IQ¢â$ýHš =ô’½Å=Mí¡>ôW´ÿ£ÿ²3üÐjmHÂÀb-‘3ÃyoÞ÷âí;I¾ž|³š¼TÐÕÇIG+øë¨6tÒP¥¹j*EW¿M*ûJÐ_áÛê~ü9a²ý2ù¼}’z[ò–­ªíjª¥âª®k4vñêÚÐ×°ðúÃï^U­D£¼ÒB£á÷ìI©Þ±ºlxÞÚOڔªå’©RUðªáº”ŠµÝÂð¦
ޕ?®¾‡à–‚+%!ð×h½ªu!„³¾>¥—°Ž[o/¥ª”‚]®Ho¡Qý¡ß³çòR°Ø¯“¼ÆuËÞ|²v«ï-/ʎö„V/èÁ£“Ó’´8æô?Ꮛ4ڍ®`q¹”`…‘®­É®7é,žyÛ
giÿµ·Ó1B·àxŠk–¤dðÇÅaæ”:¤g~w–d)9*
ÖÅ堅øo|j”¤æþl¿bn’Ãgw¤ÑÂÌîñˆÇ£„¤#äOÏ @7-Æ/¶†¹ðÌ?§I4‡À0›ã(¥ÇYRy4’% e£ù9ÝK£YÇ°bNfY’>¤{Ñ´€ÒÀ‘¦½+fc[zÙn}¶kãÜÉb:Lä›ìf;™ÍiË ½:éŒÌmڕ6ÛSXÁ¶Ëº‚Gãè•ù÷cB‘Öègð¢õ¼X=u!ê@ˆ¶’„ƒ[lÀ­g· {ˆpÞvߘßãv»¬ŒY ©nYŽ89#=PRÑ«`ÃH6″@5’yR$d|%gF”’è(ËÇ7!‚Ò–”—u•K8Øa@̺^sJÝ¢É
ˆÔ-ˆâ#,>Æv©ÉÅG »õçÔ­úŸñY—–èØla8-›ÍÓãyº?,/«š¯0³ûü߂œt£º^·r ZÕ8QlLcµÜV×í²º» ^ä°8-ò* œ,½ñB
Y¨w€i´¨4)0rÝ¡jEÉÏ)̚K(n_çS#wó]Aƒaurݾ
^ Ý5»)FÐ}:­út‰^صÙP#Ù|BÄ’Õ(ìêi®¡Ø”Opï÷îLÂë{FÒc`2ÔFHj ½¥­´´­1“§/áó?ðOqc:Ó·´Êq¤Ò¾-;Õ¦(àçÔ):ËJY9T
Š²)Ë`ô³úiʐ«¢ç’aŒ’ôð1’ôtnO$Ø>ÑE2:ÿ’³9…–$PDçÉh1Ÿíèâà 0M ã ü3²0 SµªOã·o åç—J…ñE´ ÷;¥±ÙÁ`¯BWìص ´A¡mXâÕčEHaŒt×EÆé)ÿ’žlaO®“q6ݎ-×Mh÷3A׊½ŒIè´á”>4v˜€’ŠJnN,ƅުÎÅþÝ»o~ Ø°¶Ø¼Ì»¼‚QL£”+¹ÐI‹ó6ºKq³ sÐÖ7´æfw€ì4°y§ÄqÎi´ÞÈN‹ç‹TëäÔxÎarhVdiieûA1¦ö­L³ã,ÏÂò4Kb[o-¨ºOÊúÇ2ÔEÝ5›%b®ŒÏŠuJ_ŒWrç(c»yä†/ˆšÎ¾˜Í²4ˏ
â_N·sno°)†HÞn Åb£(Ô~þEÙw’Áöl² 1YÔö¸µ¾
;N/ÆnmJ :(–åØq±–”ÐU;¶pÿÁC¤f2E{¥P8æÅ}êº*|»Ýïp>UëâŒàÐ4!9ž}8Ï­QJŽq
zl°£2MaIŠXkf:rº[ºÀ‹3œÜû.Ã$§ê@;K—;ðoNo¾(+Ôò‰†¡Õ=÷ìð·Á½½°b7ûÞd’;@#rGŒ£hD;¦cïˆÏ‡±EaV½ã„²ïI­é3qP @‹ãÂNò~ŽÇ&zÛÒd7ŠGX݀5±wùBÄ(^P@¸Îž8% Ap`ÅB#ÆïVì¢~?L}$…ñ©zûÀIš^¯kÞâÚ-¡ºw‹+ðd èþ^èf¢²upßã¢×¸ÌúU¼—ëp|?ÛÑ{彯Kôkª]‘zãâ’
¤=w ãY”Ñ$›FC• ìädËÍ®ÀŠ$¨Á>í=XØaNð@À@lƒ¦ÍۍîL_‡cIk6JcrN‹€Üî=§QÚJŽ5埒x¯€[ŸsàŠ+ÝÀ‰j÷ ߛ»ÐÚaChÝMqÐ
ðöìZý°A#¸X­BûJˆ:0wÐPÿÙ¹xÛ躿þõ—Šªö¤m„ÝF#tú%õñ ¶Ãºƒ„”¨

*Ëñ«¾ñ–ã!•ef).¥šÔ•Sô*uùï
¨ZhM@ñk¡Ÿ,܀&0~î(5ã)Ñ ü/ÔÁ ïIDt…ßË
U=Ðo.w:íSÄXâ‘]/2 ³Ø@>Zd)˜’™å”ô……1q*+ô‘Xѝæ®NèÎx,E$Ú¹ÑXš±Øó]Íî
h
’Ö¥vLº©Cõ+Z¨-àmLî”{5w8Êþ`¬ :ê“9”Îi÷ÉZ“wØÆksĪÉ[ð_Úµr§Œ™Ø2e&·&{GvvÞ-ïPX
`Ä#Aä×UV¨ŠG§av։¨Ü÷ÈÑN°X1rýÖXéB°Y•i±’bî‡ôØÂR݁ïp˶ ™NÕ&Ԉ¬Fv¢=¬#“—÷²¾^æ¾xQ¾øze¶€òjµ^U«wÔËey1Mõ¹ÄgLÐ_ æ˜æ–µáàtˆ$(+6KF½C¶9T´¨‚­
0™‚¢›®åàSŠõrRk†šÐ{…R°é–!¸Áþþ^ûˆÇ«ú;Ë«†áìØ˯´o§–ê
}þ¨?èÀâ3?¨O_>‰¸$¦[M•Ó9©.«ñ”k5q©²¢a¶Îo`?ìfL ß»)!0.ðŠÀÏ~&ð·?ø‰À³ßø7&ðoü©À3ßø×D
ƒÿDÄþJà¾)ð´À7¾.ð5§žøªÀ¿øŠ8:җðy!ð˜À¾(ð¸ÀNÌпOà,ÒÝ+äÍ{EJ·7»˜]`ž@YàŽ¢ž/â÷Ž
Ü’p¯À=w|ì+Êþ¹À§>%pLàA>)ðôð‹e·8(p›À[ö‹R}BîrDȨCŸ¯íVY«
:gÎIuœ áhÀŠðûdVåþNì=½j´“oÞ|ф&i~(
O’Ž*þèHt’ij¿7Ü¥•ùÛøƪŒø²êã+Éá/ceÞ_’õ­íX³Ýp¨ü€‰òÚ£Ñvu„%BMñóe«Šs¡Áp´eNüé‡×ôi}íd /¯@ÑòĶœ›ï¶®ÙÀëAwæÖ¤vëbSls¥«Î aƒ‹ÆR¹Ì´”.âdtÊ1KayPËóÎÐ+º¦Ç‹X¿JOd^«Ïú»ê³^«ïúvaØáìkg|*îpŽ)Ú.ŸT´…¼Jȏ
9]ÈJ— 2Ÿ0´Ø|[Åî÷:v»Ê
ìÕ'(“æÑjW»çeáÖئ‹Ù¸ìÝÉŗqØ6!´`·#>Qî*sù=|r„=îÚ캜¥†¦e9-´’¥¦¦Ì™nC³/«Ve®Î¾ÓØԚµ÷Ù܍½´ØÜä2ù±Ùñ=S (Z™·C+÷v†´B¾¡›Šw(=è;ü¥„¢;GìÁ f*q(½p$vQo“Ÿ&S4ŸyŠš^®P=!­RõhåÂXNo(ªx7b¸ñDGTïÎ F:I·`ŸæDz¸…L&~5O¿ LÒ¾kž
¾´Æ
†ür>Iò +ÖÔlg !çƒ;y½ž_û¬”á”OP„›/”¦J‡pãBîJ×͆pó…fë…l¦
_§üenÓeòb7](S/”A/Ôp…rôBùnèËc$h‹Bvz¡a]Ñ}5o;
§¿Jýebi‰/¡ù)?¥L¿ˆ®=]6NG™UòÑÜÇ­ 
æ£ô ÙEëÙ}Ôa8*hÒw¿EË¡?ˆxøŸ‰^º Z
€æ€hçôèÔáâõp.í¢ËÒ¿™Þ¤ù¦õ¤‚Æ¨cæ@ö€JÑ^±T@9yž¥@äÍñArpÎËC^|ñ^eYÁy¹J¤g¡žxŸÁ¥“¢ß;•¢w@6ƒ×‚/åé¼ï.Púí@¹m3 —Â6Ȝ–%mV}+ú؃|™—•¢]’¸
*@K¥ót†í§ïIç™Õ¸–ÚuÛӛÈï×í–8ÚÃuŒÜ¾7ÑQüÛæZmXL)H_/ü $óžày|,R-my›È šWÞ”%Îôú6#}»á(û™­ñM”a&º#) ¯åõôùèûr´s‰û‰(Ñ£óø©$>ÉßIæ/ä>â¿l,å>þœA|IÊçœûjڟ×Ƴ:)G•Ü÷Ün¼o܇¼o:ŸJòç“üdþ­œ£O«y߸Ÿ¯§¤¯•ä$çø²þþ”}KÌûeIŸÏ¤‚ä܀%â’“6:™ìÏÉøÉ~íKÚn_²|mÔ
CNŽ§–Û >»ˆñ}rŠµ‚ùÊmªë’žà2çb.’Ó§9_O|N‹3 Co_¸ïëãÖ}Â×o†ðæüL.Yô6/ä~㶹ç嗡ï¿à2çñå|½ò5s=çk˜¯£ëx÷_ۜ‹5Y*Ôç·÷ïàbíóõ÷%Î׳>§i)è_@ߝ@«aë¾¾Rôõz ô4’Ôàktò Ýo8Cíл¢×ý0ß?“ë,ƒ·;à²|%n9yó>E¤Ïé.S[.ӖËl󩘯UÓIªC¶6|~ 4
zŠ“q7}3ÙÏ¥É~¯Nöws²ïùɾO¯±R±Ò
gš7dˆßàæã âtrÂKå°tÎF3yËc…öÖ5ž˜$mtÏjqu½çú;ß’.ӐÛ$û>Ãöã.ŸË¯:}/-j_Öäs™Sʅ²4ÚÅÝÙ©]%}}GºŽv¿×ýë®O#Ÿv§¹g•wßÖèúy×’]¦í§h.^¤¸¯õãE³…¿=ý“Ôã?×L“Eüe²àö_5Ÿ’vËbÜ«eGpŠ*y‚hí,}–ËËnËAˢe¯ù)ó>óÓæÑҁ’%»K–ì)+Ù»r {àЦC‘g»8´û¹§žÛwèð¡‰ó}çÎ8¿ûÜÁs{΍ÛûîSïî;øüÄùcç_úäÉO«r;óûòäïÎ?˜¿’,ïý££FwÝ3:6ºwôÈè£GGþ`ôÅÜí’©Ïß«v(ÑÎh´sŠÙ™ÕVîèõ©½>ûž4YÎ)•c¿À-À˜]_œç–å¹sæð7:^ìÞ¥ÇòÙËû{ñ6˜¤ð¸´a‰“sãݜ—Œ›îY‚jД_, aoś¡ÅK%«J­kTÿÝùÏEØB|>ùxQ‘Ïáðíð÷
²Çܯ¿w­Gü¦Õ`§Ç1öƒž =zôè‡
 ½úµùf|Áé‹Æߒ5r±äÇÓ±ÞäÏ:Ü1:ôã¾Ïð¸7.”Ã_â‚áG¦^”çИ–‹WÆ&e^õ[gßbéRj6—jn‰Ùosž *X¨êE·-ϝž-;Z®70ARºm’ªÜié6²¥Kõ ªsE^jš-[äeÛ ¥.KÎ3§fçéyyæ¼ìÔÛAæéi˜„¼`¦B™6rèÈl¤q©ve²¶/¾9þÂf¶•ZãÇ._Žcë~ó¶ÎÔß?°‰ígxm²ýW–3#ëŽ?ÿáqÖ͌ÄâßfEl£ÑÇý·DŒY’¹SY
+¢Â±IÜò­³ÎËÖ¬HOc*›N϶¤Yª§°Ò’.ÅÈb;«¥#f§Ã—b9鶳,fµÚޙ”™žŒ¥[¾{‰iÙ¶ ·ƒ9枛¤’?±ÜìdŒÆ•j^ˆ‘;Rü¢ù‡í2þ¦ÍoM·ËÂT²’u9˜uڌ«¨çZ
eëí 7#³˜yP‹Jߺ¤vQ~^~^n®ZR¢™ssòj-YÊ6ª’Ym¼³õÌ?&^ñ®jpÌR­C,eŸŽÎ2fgØξvøÙ¶KÖ£_½thò廿–HÐêÄÓiS/+¥Í’³ÎB÷J|†®s+f+mŽ9òšÃ“4Ü!~òÛ$wõŸÕj]ÌàÈ,Y,½²9¶ û†z¸Þ¡Ô¯Ö…ÿÃ3¬‘=ôûðûp3AœúË3‡øˆÍ™éÿÎ×÷?T¯‘FaŸ#‰„Ž‰×®¾Ô¥ÿ´+}óªö²«ÿõ”(1–l%‹V%e3äÜÆTÄvÐ}I™á,øç¤lÀý4‘”%ZÀғ²rMR6C^çÝ:ðÀ¶Þîž!eag™Rãr-ªt-Uš”÷÷E††*۝÷†·uU)
}}ŠPT¶E#ÛvDºªü«ZšV9×ööG+Û·ö‡·ÜL
yi+
д
קn¤†`À…ԉ˪B5xÒ¸h.….ZŠxEè~¸.­!¤¶Qš÷·áÊQäö_«mPÄ”àð@®Ù@~°5®Âõx-´û…N»øõ};êàu~•V%ô¶Bãš÷ߥ#VÑÃô(üп¨¯ŠVîj¼þ¥äz+%ãÛ5&6ήÿ5ÍJ…¦ù_oK•xÒ$gÐ0 ¨õ3X
endstream
endobj
4 0 obj
>stream
hÞ4ÛŠÂ0†_e.wY$‡FmA
žª» ˆ)»âE(ƒÒ¦´s¡o¿IêÞ}3ß?“‰HpÉÄTÁbÁÖκ^w¦ÂP)H!|âì9ó,ç9Û>h§ÉPHí´ð&‰©–žÕ+U¸–| ~}áµä#&Ç©²” æÿS§ÞUéÂN›‚•ø kžû-ˡ– ‚­M·Çúv’˜Í$Ûàh&~+¬¹
¨øöj嗉˜¥Þ‰çÒ,½FY˜¦¶Ï·²npx;µE ãI¡>šÙr{øÚ>blrvi£ÓÔ#Uwvt}cllýŒ’)ÎÙ'[WËöf8ӄÍRá;@ùì0΄Ûûº#׳ßחԔçùŸ óu›
endstream
endobj
5 0 obj
>
endobj
6 0 obj
>stream
hÞ¬—Ëo7ƔÄ]í¶j
–]+bÑ&à&ЊÏ}8EuÒ ½F·8′-Т½øп3$W–lIñC ¯õ Ãùf¾áâÓgÍÿ¼þº.~SñåÖKøÛrãªRWÊÁCi*iøòŸ¡ôï)þ7Ë¿†a…OŸÕj1S&|~­êR˝¶ð³Q¸Üâê¶á7·ðÑۛ‡¥T•Åe¿ˆk©Ü÷E[6″Ÿ®E?¡ÓâëòwXWÇu#‰„õJ«Ëm[—µ­+w^J).OFVˆùE¼›°™rø—Ы,gÅÜhYZQâO1o!2-.=¨äsUÚ¶u|ù!à˜ˆ£qH¡Ú²ƒ,)”*•8¢9ËxÎH¯˜˜)9O³Ñw9¹à Å3!é˜ã›F¤Å¼ô>|VÈS
Á8¶°À÷pùatw4ô5Mòñ0¿OVÌ©‚]àxµ€ï–Fð¾uEÏ9ËÏH2£¯ØyÉßÂƪÑ^±)¾Š„®tbÛöÍÚöJê°¿eô4’12XNÈ)Y#j :ŒS+)ž—Ü¿½Ë“Ú®òÓÉEÙ&0- Ԋ)ð(Íœï «°_òSF&4ÅsVÊÜ;çC(Ù8ߣ©jgvªÚàSÌ䆀ØI֛‚dftšºN.*ëñ@U ª”(hÏnìÞnºiYè!½‚†%´ßl¾5|íìþ ‘dÄòì”é(°ÝTâéÊ@(2#ÜZñH,ž YSGÉ&§4ÏÇlœÐ#P­^³“„uºmȶ)B›½XÁàñ£¼/ïé¡«”itW@?F‡È„mΊ“l
+ʗ7ÞÀ¥ËÀ]·+líÜ&—
3F¦4Á^܈o/î%uWʐ0·ÑlïªE;½_8I×îX¾^éµ(Ÿ’H#ê­âÑÒmaqw,ތÀŠ&ß©^’¶; «!˜`sSʦmvçMÇ*{ƒ–×pž~Èֈ%5øÅÀÈqìؔ¿³@mÕKQQô¯]w­Î5ÎN²`Ù-ÁKÝ{‚±O¬ù­ºPZ¨{Æ°a`«„¸²Y6 +Áp@ŽsHdš%t²ÃÁBʽ…É­my#È{)¨Õlˆª:àa|«è4t‚;{Ø8ÛÉü
;öʆ¼åô4Fåoàûý8wO™—O©Äò¦@‘ºƒ’EJb>à“µ:”‰«t¶…pÎtÃ^NS
¸Ó?!Iš“Œ‚¤aÛì&¿®Ûãš&&â§íòD‘¨§l½­ÁèËSÞj
G‘z3HXþŠMÆq{¶«:pÀãúZÀë)ÃV¨«jk?^!àI4Ñ æ‡9„¨Ú !ÇçØÇüFµù¦Â8¾yb’x:“„œ±ƒP¡zߐÜúJSnÝÓT”E½ÙÍÚ¶«Ôބæ½,aDZp”çþÚwñë¸ßxöàdÈ’,¹oöíŽÅ/Z/RݨZB1ÐÆ îFÙî@#†IJƒ5ö“1v{ùØ!ò‡OÞ>P¹j¥?ýq„-Ÿ?…¼áüCQ·ÀðZ´Ê1ø‡‘O[È,üš%SÆAêþæ©mûˆN¸AÛÞÿdGk=myuÉ?¢^Ñqa¾Qhg’ˬ>ÄÝ·ë½
êýÖ²ÓûðÉiT?zwŒ>˜^{»Ø@CÇÇåð XÄ߄
endstream
endobj
7 0 obj
>stream
hÞ,Ê1€ DÑ«pŒZZ”vƂ:#F·àø.J÷’o˜èHC¤¤c:Òí.bÏ@8c(‹RtÎ`x(bCE°9v[_:€]¼ÿ#óæO)êÓÞ)¸µ“¦kÌ°+õ
0 Fš”À
endstream
endobj
8 0 obj
>
endobj
9 0 obj
>stream
hÞl”[oÓ0Ç¥9‹sj·”Mc¥†QdwŠëkKŒv“x]ÞVž*†ô/Àç8—v“¦J®cÇÿß9ÿsâå흔?6ɗ&YÞH”Ió8″à爭¹tª&Úr]
MšÇD´[’ü‚Y³öÃ߄ÖüL®AàöNnµt§%uwMÉ]¥AV.u-½ÞòrS“õÞݬ’H[y]˜8Õj¯`iŽWìÍGâ‡p1ð™.oTèƒ>`Q9CŒ+¹õJIÁ…µ×„P½è=ýlX!]i¹¢ÿXQ ÉKŠ£8r¯éø C) 1ð,).é8Íò”}k¾BڅäÆ9Kš«Žàz‚2UGØc5½‚ƒ¶•äv@UôˆiÁ3 ¼š²
ðhÄ
%`ÅhœF8‹³É)‰Ó _Žwd˜-YäŽûžY+ÚñÜîÄÀ•4g‚¾NgùaLñ ñÞk” ˜tp&|‹_LQڝ~E?´£ÏL”b—™¢y¦S&%
ÈÁw‚Í¢W¥è}útöîŒÆš
˜Ÿ£ãÅiNH–¼C–¢Sr

Читайте также:  Кедровый орех и сахарный диабет 1 типа

>ô¿É¡Í0
]»ƒÓk{kÈ(=ї|JŸŠ>§•Uˆí©$âñ”ýîÄV{øqOüŸMm/✠´¤®PûÛAg…‰åXQBdN!’Nw-˜…2½ÿܶïX»O+ð*ÛUSêU@ÎP¯ZŠÉJF{º.•©Tî•àÏÙøÿPÁìE²+é3ys9’pÓ,|Xèì16Ü=Öܑ‘á4ô…ñ:š¦ ×ÈðöDIðNäs&?7̝‡y×$¬_]Ӕđ½”‰Á Zûó ,´ž3ŸÛ´¢Øî2kŸHîâ’Lýû{‘~ÐݤÔÔ僆ªüç3GÝd½vnŠµôãD̒,ÙåKÖ&‡N!Ù8¥öÑCÀN|ÁgQ³˜§²l’¢¯­íšŽ+ípÂ>©v @¯1ºÃ³kΞJñHÈß”z6Áø)’ØZ ’C1iƒsåF▻ Ž¸=˜k|µ©Ûڏn{:ð~BGÃûÚìê2Ùé/ØÁ‡’Ê™9HrR¾=ÒÏ~…Ñ^ó4Þ :,%[hdqÐ/â7V5t¹oՉŠöîtY¼Äô©¡?š¨ªk?-¦¯4ö¹uÎÕÐöúÁN”mH1Âf褈]ùÕx7Q(y®!m¾È›àÖàÝ0¸Îôᣥ-‘`n^vs,e´#áãØ¢t^x‹­~¹¤o(þ‡H‰a#‹Æ£G¿ŠÝcãî
úd°›ö[éþÃk3úthJMuk Fµm]œ/||ýùÖÑý²éT‡… 8”Úxá®åàët†™kN@ò¾jŽÛ‰ÀñþÞè@‰ã8yì $â„’”£S})ªúþN1h3}ݾšŸŸîØQõh_;Ýl(µéºƒ·ö3ŏù|Z4TøóVƒ¨*s•ö߸é{}zóäœ1k©‰“cëª)³ÕŸpl]S?ã®æ;s^²‹Å¦!ùÉ?xpä/˜ž§ÿ` ø=ïô
endstream
endobj
13 0 obj
>stream
hÞ,Ì1„ …á«Ì
`ÀD
C£Ž­:caÝf1:…Çßa±ûÉ÷´4têó’_á܏T·ƒ(²x¯Æ‡§À;™ŠØ”ÒFºyW”¿,*Þþ„®i%ë5€mÄh~?˜¯|„Ä«šR1=¼yÿ` ^Õ’q
endstream
endobj
14 0 obj
>
endobj
15 0 obj
>stream
hޔX]oÛÈ:’†ô¶$S°¢µ¬Y,‰LsøÍ~ IÓî.úº~kú lѾä¡¿çޙ¡(%rp(‰¼sçÜsϹÃǟ~)ô¯Ÿ/þütñø£ÑF?ýó¢×9þõºî2ӝ.ë¬lòR?ýû”矌þ®ž>џÿ^$MúôÛÅ_à§_Ì«°±Œ{“§hyÛWº.ª¬orCá?|îô§Ï¸õó§ÿ

Источник

  • блоги
  • группы
  • медицинская техника
  • бактерицидный облучатель рециркулятор дезар 5
  • Анализы в Волгограде
  • Новости партнеров
  • Все обо всем
  • My Doc – Медицинская помощь в удобном формате
  • Массаж в Москве
  • Современное протезирование зубов в Москве
  • вакансии для медработников
  • Как бросить курить и сохранить улыбку?
  • Донорство яйцеклеток
  • Донорство яйцеклеток
  • DentalWay – стоматология в Химках
  • Мучают головные боли?
  • Провизор

Блог пользователя Иван Пожаров

Иван Пожаров06 апреля, 11:52

1.United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
2.National Institute for Health and Clinical Excellence. Type 2 Diabetes. National clinical guideline for management in primary and secondary care (update) London: NICE, 2008.
3.Williams B, Poulter NR, Brown MJ, Davis M, et al. Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
4.ADVANCE Collaborative Group. Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes mellitus: results of the ADVANCE trial. N Engl J Med 2008;358:2560-72.
5.The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes Volume N Engl J Med 2008, 358:2545-59.
6.Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011; 6:CD008143.
7.Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011;343:d4169.
8.Yudkin JS, Richter B, Gale EAM. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010;53:2079-85.
9.Institute for Quality and Efficiency in Health Care. Benefit assessment of long-term blood glucose lowering to near normal levels in patients with type 2 diabetes mellitus. IQWIG, 2011.
10.United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 1998;33:123-55.
11.Hannson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet1998;351:1755-62.
12.Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
13.Beradis et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009;339:b4531.
14.Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
15.Le Roith D. Current therapeutic algorithms for type 2 diabetes. Clin Cornerstone 2001;4:38-49.
16.UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
17.Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360-72.
18.American Association of Clinical Endocrinologists. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management–2000 update. Endocrine Practice 2000;6:43-84.
19.Kahn S et al. for The ADOPT Study Group. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. N Engl J Med2006;355:2427-43.
20.Home P, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M et al. for the RECORD Study Group. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes: the RECORD clinical trial. Lancet 2009;373:2125-35.
21.https://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/09/news_detail_001119.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1

Читайте также:  Диета при сахарном диабете диета 6

22.https://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1

23.Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S et al. on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia 2009;52(10):2046-55.
24.Holman R, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF et al. for the 4-T Study Group. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes N Engl J Med 2009;361:1736-47.

 

Источник